rs75087725

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004928.3(CFAP410):​c.172G>T​(p.Val58Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00998 in 1,612,464 control chromosomes in the GnomAD database, including 105 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0088 ( 16 hom., cov: 34)
Exomes 𝑓: 0.010 ( 89 hom. )

Consequence

CFAP410
NM_004928.3 missense

Scores

16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.292

Publications

19 publications found
Variant links:
Genes affected
CFAP410 (HGNC:1260): (cilia and flagella associated protein 410) Four alternatively spliced transcript variants encoding four different isoforms have been found for this nuclear gene. All isoforms contain leucine-rich repeats. Three of these isoforms are mitochondrial proteins and one of them lacks the target peptide, so is not located in mitochondrion. This gene is down-regulated in Down syndrome (DS) brain, which may represent mitochondrial dysfunction in DS patients. [provided by RefSeq, Sep 2012]
CFAP410 Gene-Disease associations (from GenCC):
  • axial spondylometaphyseal dysplasia
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • amyotrophic lateral sclerosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0025855005).
BP6
Variant 21-44333234-C-A is Benign according to our data. Variant chr21-44333234-C-A is described in ClinVar as [Benign]. Clinvar id is 259585.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00882 (1344/152380) while in subpopulation AMR AF = 0.0119 (182/15314). AF 95% confidence interval is 0.0112. There are 16 homozygotes in GnomAd4. There are 712 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 16 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CFAP410NM_004928.3 linkc.172G>T p.Val58Leu missense_variant Exon 4 of 7 ENST00000339818.9 NP_004919.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CFAP410ENST00000339818.9 linkc.172G>T p.Val58Leu missense_variant Exon 4 of 7 1 NM_004928.3 ENSP00000344566.4 O43822-1

Frequencies

GnomAD3 genomes
AF:
0.00882
AC:
1343
AN:
152262
Hom.:
16
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00171
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0119
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00207
Gnomad FIN
AF:
0.0236
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0119
Gnomad OTH
AF:
0.00813
GnomAD2 exomes
AF:
0.00798
AC:
1933
AN:
242326
AF XY:
0.00811
show subpopulations
Gnomad AFR exome
AF:
0.00128
Gnomad AMR exome
AF:
0.00516
Gnomad ASJ exome
AF:
0.000407
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0227
Gnomad NFE exome
AF:
0.0109
Gnomad OTH exome
AF:
0.00774
GnomAD4 exome
AF:
0.0101
AC:
14747
AN:
1460084
Hom.:
89
Cov.:
31
AF XY:
0.00983
AC XY:
7141
AN XY:
726240
show subpopulations
African (AFR)
AF:
0.00146
AC:
49
AN:
33466
American (AMR)
AF:
0.00484
AC:
216
AN:
44670
Ashkenazi Jewish (ASJ)
AF:
0.000306
AC:
8
AN:
26112
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39672
South Asian (SAS)
AF:
0.000964
AC:
83
AN:
86124
European-Finnish (FIN)
AF:
0.0216
AC:
1127
AN:
52196
Middle Eastern (MID)
AF:
0.00225
AC:
13
AN:
5768
European-Non Finnish (NFE)
AF:
0.0115
AC:
12771
AN:
1111718
Other (OTH)
AF:
0.00795
AC:
480
AN:
60358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
788
1576
2365
3153
3941
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
474
948
1422
1896
2370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00882
AC:
1344
AN:
152380
Hom.:
16
Cov.:
34
AF XY:
0.00956
AC XY:
712
AN XY:
74508
show subpopulations
African (AFR)
AF:
0.00171
AC:
71
AN:
41592
American (AMR)
AF:
0.0119
AC:
182
AN:
15314
Ashkenazi Jewish (ASJ)
AF:
0.000864
AC:
3
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00228
AC:
11
AN:
4834
European-Finnish (FIN)
AF:
0.0236
AC:
251
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0119
AC:
808
AN:
68034
Other (OTH)
AF:
0.00804
AC:
17
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
76
152
227
303
379
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00960
Hom.:
17
Bravo
AF:
0.00673
TwinsUK
AF:
0.0127
AC:
47
ALSPAC
AF:
0.0140
AC:
54
ESP6500AA
AF:
0.000682
AC:
3
ESP6500EA
AF:
0.0106
AC:
91
ExAC
AF:
0.00731
AC:
887
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.0109
EpiControl
AF:
0.0106

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Dec 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CFAP410: BP4, BS1, BS2 -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.75
T
BayesDel_noAF
Benign
-0.84
CADD
Benign
10
DANN
Benign
0.86
DEOGEN2
Benign
0.0064
T;.;.
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.076
N
LIST_S2
Benign
0.82
T;T;T
MetaRNN
Benign
0.0026
T;T;T
MetaSVM
Benign
-0.92
T
PhyloP100
-0.29
PROVEAN
Benign
-0.22
N;N;N
REVEL
Benign
0.023
Sift
Benign
0.48
T;T;T
Sift4G
Benign
1.0
T;T;T
Polyphen
0.015
B;.;.
Vest4
0.26
MutPred
0.46
Gain of disorder (P = 0.1069);Gain of disorder (P = 0.1069);Gain of disorder (P = 0.1069);
MVP
0.061
MPC
0.25
ClinPred
0.0084
T
GERP RS
-0.56
Varity_R
0.041
gMVP
0.25
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs75087725; hg19: chr21-45753117; COSMIC: COSV99045877; COSMIC: COSV99045877; API